Protein arginine methyltransferase 5 is implicated in the aggressiveness of human hepatocellular carcinoma and controls the invasive activity of cancer cells-Reference-Cited by-同舟云学术

Protein arginine methyltransferase 5 is implicated in the aggressiveness of human hepatocellular carcinoma and controls the invasive activity of cancer cells

Published:2018-04-25 Issue: Volume: Page:
ISSN:1021-335X
Container-title:Oncology Reports
language:
Short-container-title:Oncol Rep

Author:

Jeon Ju-Yeon¹,Lee Jee¹,Park Eun-Ran¹,Shen Yan¹,Kim Mi-Yeun¹,Shin Hyun-Jin¹,Joo Hyun-Yoo¹,Cho Eung-Ho²,Moon Sun²,Shin Ui²,Park Sun³,Han Chul⁴,Choi Dong⁵,Gu Man⁶,Kim Sang-Bum²,Lee Kee-Ho¹

Affiliation:

1. Division of Radiation Cancer Research, Korea Institute of Radiological and Medical Sciences, Seoul 01812, Republic of Korea

2. Department of Surgery, Korea Institute of Radiological and Medical Sciences, Seoul 01812, Republic of Korea

3. Department of Pathology, Korea Institute of Radiological and Medical Sciences, Seoul 01812, Republic of Korea

4. Department of Internal Medicine, Korea Institute of Radiological and Medical Sciences, Seoul 01812, Republic of Korea

5. Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Republic of Korea

6. Department of Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul 02841, Republic of Korea

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,General Medicine

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PRMT5 Mediated HIF1α Signaling and Ras-Related Nuclear Protein as Promising Biomarker in Hepatocellular Carcinoma;Biology;2024-03-27

2. Chemoinformatic Catalyst Selection Methods for the Optimization of Copper–Bis(oxazoline)-Mediated, Asymmetric, Vinylogous Mukaiyama Aldol Reactions;ACS Catalysis;2024-02-06

3. Nuclear to cytoplasmic transport is a druggable dependency in MYC-driven hepatocellular carcinoma;Nature Communications;2024-02-01

4. Glioblastoma with PRMT5 gene upregulation is a key target for tumor cell regression;Oncologie;2024-01-23

5. Phase 1 Study of JNJ-64619178, a Protein Arginine Methyltransferase 5 Inhibitor, in Advanced Solid Tumors;Clinical Cancer Research;2023-08-01